now your saying they are doing phase 2. You were fighting with me for days saying they arnt doing any in human trials for the next 10 years and need multiple phase trials and years of waiting and the company is worthless.
Hawk70 you keep on avoiding the question why was MSB a 350 million market cap on preclinical studies results? Also why was AGN a 100 million market cap on preclinical studies results? Answer me hurry up
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)